ibrexafungerp

ibrexafungerp Scynexis Announces Submission of New Drug Application to the U.S. Food and Drug Administration for Oral Ibrexafungerp for the Treatment of Vaginal Yeast Infection JERSEY CITY, N.J., Oct. 14, 2020 (GLOBE NEWSWIRE) — SCYNEXIS,

On most days, I have a really hard time concentrating and sitting still. I have been struggling with this for a long time and I am beginning to wonder if I have attention deficit hyperactivity disorder (ADHD). Do you recommend that I see someone once COVID-19 calms down a bit?

Excellent question, thank you for asking. ADHD (attention deficit hyperactivity disorder) may be more common than you think! According to the Center for Disease Control (CDC), 9.4% of all school age children have ADHD, but

How do I deal with burnout in school?

Thanks for your question. Many teens share this concern. Here are some things to consider. First, it’s important to understand the source of your burnout. Is it because you’re struggling with a specific class (or

ripretinib

ripretinib Deciphera Pharmaceuticals Announces U.S. Food And Drug Administration Acceptance Of New Drug Application And Priority Review For Ripretinib In Patients With Advanced Gastrointestinal Stromal Tumors WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 12, 2020– Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced